Smithfield Trust’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-6,613
| Closed | -$371K | – | 962 |
|
|
2018
Q4 | $371K | Hold |
6,613
| – | – | 0.04% | 161 |
|
|
2018
Q3 | $541K | Sell |
6,613
-2,631
| -28% | -$215K | 0.06% | 147 |
|
|
2018
Q2 | $323K | Hold |
9,244
| – | – | 0.04% | 198 |
|
|
2018
Q1 | $190K | Hold |
9,244
| – | – | 0.02% | 282 |
|
|
2017
Q4 | $262K | Hold |
9,244
| – | – | 0.03% | 231 |
|
|
2017
Q3 | $287K | Hold |
9,244
| – | – | 0.04% | 216 |
|
|
2017
Q2 | $292K | Hold |
9,244
| – | – | 0.04% | 217 |
|
|
2017
Q1 | $209K | Hold |
9,244
| – | – | 0.03% | 261 |
|
|
2016
Q4 | $202K | Buy |
9,244
+4,498
| +95% | +$98.3K | 0.03% | 280 |
|
|
2016
Q3 | $125K | Hold |
4,746
| – | – | 0.02% | 357 |
|
|
2016
Q2 | $94K | Buy |
+4,746
| New | +$94K | 0.02% | 397 |
|